Editorial: A Cry for Help: We Need Nonpharmacological Randomized Controlled Trials for Pediatric Irritability

Area of Science:

• Pediatric Psychiatry
• Child and Adolescent Psychology
• Clinical Psychology

Background:

• Significant research advances in assessing, diagnosing, and treating clinically impairing irritability in children and adolescents over recent decades.
• Historical controversy in the 1990s regarding the classification of severe nonepisodic irritability in youth, leading to the inclusion of disruptive mood dysregulation disorder in DSM-5.
• Contemporary conceptualization of irritability as a transdiagnostic symptom across various pediatric disorders, including mood, anxiety, disruptive behavior, and neurodevelopmental conditions.

Discussion:

• The transdiagnostic approach to irritability acknowledges its presence across multiple pediatric mental health conditions.
• This perspective necessitates a review of interventions applicable to a broad range of presentations.
• The meta-analysis by Breaux et al. provides a timely synthesis of current treatment options.

Key Insights:

• Irritability in youth is increasingly understood as a symptom rather than a standalone disorder.
• This transdiagnostic view impacts how interventions are evaluated and applied.
• Pharmacological and nonpharmacological interventions are crucial for managing irritability across diverse diagnoses.

Outlook:

• Future research should continue to explore the efficacy of interventions within this transdiagnostic framework.
• Further investigation into the underlying mechanisms of transdiagnostic irritability is warranted.
• Clinical practice should integrate evidence-based treatments for irritability across various pediatric mental health services.